ADIL Nasdaq· Adial Pharmaceuticals Inc.
FundamentalsNews digest Peer analysis
ADIL Nasdaq· Adial Pharmaceuticals Inc.
Earnings report Q3 2023

ADIL Reports Decrease in Revenue for the Latest Quarter

Segments of Revenue

ADIL's revenue for the latest quarter was not explicitly mentioned in the provided context block. However, based on the condensed consolidated statements of operations, the company's total operating expenses for the quarter were $1.36 million. This suggests that the revenue generated during the quarter was lower than the expenses incurred.


ADIL's management did not provide specific comments on the company's financial performance or revenue in the provided context block. However, it is worth noting that ADIL's research and development expenses decreased from $696,073 in the same quarter last year to $207,128 in the latest quarter. This reduction in R&D expenses could indicate a more efficient allocation of resources and potentially contribute to future cost savings.


ADIL faced a challenge in the latest quarter as its revenue was not sufficient to cover its operating expenses. The company reported a loss from operations of $1.36 million, which indicates a negative financial performance for the quarter. This could be attributed to various factors such as lower sales, increased costs, or other operational challenges.


ADIL's interest income increased from $3,472 in the same quarter last year to $10,236 in the latest quarter. This suggests that the company earned more interest on its investments during the quarter. While this increase in interest income is not significant in comparison to the overall financial performance, it could contribute positively to the company's overall financial position.


ADIL reported a decrease in revenue for the latest quarter, resulting in a loss from operations. The company's research and development expenses decreased, indicating potential cost savings. However, the revenue generated was not sufficient to cover the operating expenses, posing a challenge for the company. ADIL did experience an increase in interest income, which could have a positive impact on its overall financial position. Overall, ADIL's financial performance in the latest quarter was below expectations, and the company will need to address the challenges it faces to improve its revenue generation and profitability.

Source documents

Form 10-Q  filed on Nov 14, 2023
25 pages scanned

Reference data

Company financials Q3 revenue 0
Analyst estimates Q3 EPS missed by -67.40%
Sign up to Fey

Get in-depth analysis on thousands of stocks for just $30/month. Cancel anytime.